2024-10-27 03:48:33 :
Novartis India’s second quarter results released live: Novartis India announced its second quarter results on October 25, 2024, reporting revenue growth of 10.59% year-on-year. However, the company faced challenges, with profits falling by 13.81% during the same period.
Compared with the previous quarter, Novartis’ revenue fell by 5.62%, and its profit dropped significantly by 20.71%. This suggests potential headwinds the company may need to address in the future.
It is worth noting that selling, general and administrative (SG&A) expenses showed a positive trend, falling 5.97% month-on-month and 3.17% year-on-year. The cuts may be a strategic move to improve profitability amid rising costs.
Operating income decreased by 25.79% month-on-month, but increased by 6.89% year-on-year. The mixed performance highlights continued fluctuations in operating efficiency.
Second quarter earnings per share (EPS) were $8.27, a year-on-year decrease of 13.76%, which may worry investors looking for continued growth.
In terms of stock performance, Novartis India returned -4.82% last week, 1.07% over the past six months and an impressive 36.7% year-to-date, indicating investor sentiment A mixed bag of good and bad.
As of now, the market capitalization of Novartis India is $2,609.94 billion rupees, a new 52-week high $1248 lowest $599.95, indicating that its stock price fluctuated greatly during the year.
Novartis India Financials
period | Q2 | Q1 | month-on-month growth | Q2 | year-on-year growth |
---|---|---|---|---|---|
total revenue | 87.1 | 92.29 | -5.62% | 78.76 | +10.59% |
Total Selling/General/Administrative Expenses | 5.2 | 5.53 | -5.97% | 5.37 | -3.17% |
Depreciation/Amortization | 0.58 | 0.55 | +5.45% | 0.65 | -10.77% |
total operating expenses | 69.72 | 68.87 | +1.23% | 62.5 | +11.55% |
operating income | 17.38 | 23.42 | -25.79% | 16.26 | +6.89% |
net income before tax | 27.56 | 33.68 | -18.17% | 32.43 | -15.02% |
net income | 20.41 | 25.74 | -20.71% | 23.68 | -13.81% |
Diluted normalized earnings per share | 8.27 | 10.42 | -20.63% | 9.59 | -13.76% |
Follow us On Social Media   Twitter/X